Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    FDL169

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 1628416-28-3, Fdl169, Cftr corrector 2, 49pn4s4fdh, 2(1h)-phthalazineacetamide, 7-ethoxy-4-(3-fluorophenyl)-n-methyl-n-(2-methyl-6-benzoxazolyl)-1-oxo-, 2-(7-ethoxy-4-(3-fluorophenyl)-1-oxophthalazin-2(1h)-yl)-n-methyl-n-(2-methylbenzo(d)oxazol-6-yl)acetamide
    Molecular Formula
    C27H23FN4O4
    Molecular Weight
    486.5  g/mol
    InChI Key
    XRPSUWYWZUQALB-UHFFFAOYSA-N
    FDA UNII
    49PN4S4FDH
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    2-[7-ethoxy-4-(3-fluorophenyl)-1-oxophthalazin-2-yl]-N-methyl-N-(2-methyl-1,3-benzoxazol-6-yl)acetamide
    2.1.2 InChI
    InChI=1S/C27H23FN4O4/c1-4-35-20-9-10-21-22(14-20)27(34)32(30-26(21)17-6-5-7-18(28)12-17)15-25(33)31(3)19-8-11-23-24(13-19)36-16(2)29-23/h5-14H,4,15H2,1-3H3
    2.1.3 InChI Key
    XRPSUWYWZUQALB-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CCOC1=CC2=C(C=C1)C(=NN(C2=O)CC(=O)N(C)C3=CC4=C(C=C3)N=C(O4)C)C5=CC(=CC=C5)F
    2.2 Other Identifiers
    2.2.1 UNII
    49PN4S4FDH
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. 1628416-28-3

    2. Fdl169

    3. Cftr Corrector 2

    4. 49pn4s4fdh

    5. 2(1h)-phthalazineacetamide, 7-ethoxy-4-(3-fluorophenyl)-n-methyl-n-(2-methyl-6-benzoxazolyl)-1-oxo-

    6. 2-(7-ethoxy-4-(3-fluorophenyl)-1-oxophthalazin-2(1h)-yl)-n-methyl-n-(2-methylbenzo(d)oxazol-6-yl)acetamide

    7. 2-[7-ethoxy-4-(3-fluorophenyl)-1-oxo-1,2-dihydrophthalazin-2-yl]-n-methyl-n-(2-methyl-1,3-benzoxazol-6-yl)acetamide

    8. 2-[7-ethoxy-4-(3-fluorophenyl)-1-oxophthalazin-2-yl]-n-methyl-n-(2-methyl-1,3-benzoxazol-6-yl)acetamide

    9. 7-ethoxy-4-(3-fluorophenyl)-n-methyl-n-(2-methyl-6-benzoxazolyl)-1-oxo-2(1h)-phthalazineacetamide

    10. Cftr Corrector 2?

    11. Unii-49pn4s4fdh

    12. Schembl16048480

    13. Fdl-169

    14. Bdbm160525

    15. Fdl-169;fdl 169

    16. Bcp30546

    17. Ex-a3163

    18. S8795

    19. Zb1606

    20. Akos037515658

    21. Sb18874

    22. Hy-125381

    23. Cs-0091038

    24. Us9682969, 17

    25. Us9682969, 22

    2.4 Create Date
    2014-12-31
    3 Chemical and Physical Properties
    Molecular Weight 486.5 g/mol
    Molecular Formula C27H23FN4O4
    XLogP34.6
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count7
    Rotatable Bond Count6
    Exact Mass486.17033339 g/mol
    Monoisotopic Mass486.17033339 g/mol
    Topological Polar Surface Area88.2 Ų
    Heavy Atom Count36
    Formal Charge0
    Complexity856
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1